ACTIVE

SOFARMEX

Export PDF

Financial year 2026 · closed on 31/01/2026

Net result

2,5 M €

+25.5% YoY

Revenue

30 M €

+9.8% YoY

Equity

4,5 M €

+120.1% YoY

What does SOFARMEX do?

SOFARMEX is a Private limited company incorporated in 2016. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Woluwe-Saint-Lambert.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0654.747.129

Incorporation

17/05/2016

Legal form

Private limited company

Registered office

Avenue Emile Vandervelde 82
1200 Woluwe-Saint-Lambert · BruxellesSee on map

Contributed capital

18 550,00 €

Latest accounts

31/01/2026

Activities (NACE)

21209Manufacture of pharmaceutical preparations· main 21209Manufacture of pharmaceutical preparations 21201Manufacture of pharmaceutical preparations 21201Manufacture of pharmaceutical preparations

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 9 financial years

	2026		2025		2024		2023		2021		2020		2019		2018		2017
Income statement
Revenue	30 M €	+9.8%	27,4 M €	+14.6%	23,9 M €	+1.5%	23,5 M €	-5.6%	24,9 M €	+55.5%	16 M €	-19.5%	19,9 M €	-11.3%	22,4 M €		–
EBITDA	3,3 M €	+22.5%	2,7 M €	+19.6%	2,2 M €	+0.1%	2,2 M €	-36.4%	3,5 M €	+113%	1,6 M €	-7.2%	1,8 M €	+39.8%	1,3 M €	+4553%	-28,4 k €
Operating result	3,2 M €	+23.3%	2,6 M €	+18.2%	2,2 M €	+0.5%	2,2 M €	-7.6%	2,4 M €	+311%	584,9 k €	-18.6%	718,2 k €	+141%	298,1 k €	+1148%	-28,4 k €
Net result	2,5 M €	+25.5%	2 M €	+13.6%	1,7 M €	+0.7%	1,7 M €	-7.5%	1,8 M €	+541%	288,4 k €	-39.0%	472,7 k €	+177%	170,9 k €	+697%	-28,7 k €
Balance sheet
Equity	4,5 M €	+120%	2 M €	+2203%	88,7 k €	+31.5%	67,5 k €	-97.6%	2,8 M €	+200%	922 k €	+45.5%	633,5 k €	+294%	160,8 k €	+1692%	-10,1 k €
Total assets	5,2 M €	+103%	2,6 M €	-39.7%	4,3 M €	-35.1%	6,6 M €	+92.1%	3,4 M €	-26.7%	4,7 M €	-20.8%	5,9 M €	-19.0%	7,3 M €	+167836%	4,3 k €
Cash	–		–		166,9 k €	+230%	50,5 k €	-3.8%	52,5 k €	+2.2%	51,4 k €	-27.2%	70,6 k €	-51.5%	145,6 k €	+3335%	4,2 k €
Debts	738,5 k €	+38.6%	533 k €	-87.3%	4,2 M €	-35.8%	6,5 M €	+890%	658,4 k €	-82.5%	3,8 M €	-28.5%	5,2 M €	-26.2%	7,1 M €	+49133%	14,4 k €
Other
Workforce	–		–		–		–		0,4 ETP	-90.2%	4,1 ETP	-22.6%	5,3 ETP	-22.1%	6,8 ETP		–

Estimate

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/01/2026 · 2 active · 10 ended

Active mandates

Arnaud BERKEN

Manager · since 04 octobre 2023 · until 17 juin 2026

Active

Philippe LACROIX

Manager · since 13 mai 2016

Active

Ended mandates

Jean VEROUGSTRAETE

Manager · since 22 octobre 2022 · until 18 juin 2025

Ended

Jean VEROUGSTRAETE

Manager · since 22 octobre 2022 · until 21 septembre 2025

Ended

Arnaud BERKEN

Manager · since 01 septembre 2020 · until 20 septembre 2023

Ended

Jean VEROUGSTRAETE

Manager · since 18 septembre 2019 · until 21 septembre 2022

Ended

At this address

Other companies at this address

Company	CBE no.
PHOENIX Pharma Belgium● Active	0425.353.116

Annual accounts

Full financial information

	2026	2025	2024	2023	2022	2021
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/02/2025	01/02/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020
Closing of the financial year	31/01/2026	31/01/2025	31/01/2024	31/03/2023	31/03/2022	31/03/2021
Length of the financial year	12 months	12 months	10 months	12 months	12 months	12 months
Filing date	30/06/2026	07/07/2025	10/07/2024	17/10/2023	11/10/2022	17/09/2021
General meeting	17/06/2026	18/06/2025	19/06/2024	04/10/2023	30/09/2022	15/09/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

10 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/01/2026	17/06/2026	30/06/2026	French	PDF
Full model	31/01/2025	18/06/2025	07/07/2025	French	PDF
Full model	31/01/2024	19/06/2024	10/07/2024	French	PDF
Full model	31/03/2023	04/10/2023	17/10/2023	French	PDF
Full model	31/03/2022	30/09/2022	11/10/2022	French	PDF
Full model	31/03/2021	15/09/2021	17/09/2021	French	PDF
Full model	31/03/2020	16/10/2020	09/11/2020	French	PDF
Full model	31/03/2019	18/09/2019	30/09/2019	Dutch	PDF
Full model	31/03/2018	19/09/2018	12/10/2018	Dutch	PDF
Full model	31/03/2017	20/09/2017	20/10/2017	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/01/2026 · 2 active · 10 ended

Active mandates

Arnaud BERKEN

Manager · since 04 octobre 2023 · until 17 juin 2026

Active

Philippe LACROIX

Manager · since 13 mai 2016

Active

Ended mandates

Jean VEROUGSTRAETE

Manager · since 22 octobre 2022 · until 18 juin 2025

Ended

Jean VEROUGSTRAETE

Manager · since 22 octobre 2022 · until 21 septembre 2025

Ended

Arnaud BERKEN

Manager · since 01 septembre 2020 · until 20 septembre 2023

Ended

Jean VEROUGSTRAETE

Manager · since 18 septembre 2019 · until 21 septembre 2022

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates03/09/2026
Hernieuwing van het mandaat van één van de bestuurders van de
PDF
Mandates03/09/2026
Renouvellement du mandat d’un des administrateurs
PDF
Mandates15/07/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates15/07/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates21/11/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates21/11/2023
ONTSLAGEN - BENOEMINGEN
PDF
Other01/08/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - ASSEMBLEE GENERALE - ANNEE COMPTABLE
PDF
Other01/08/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ALGEMENE VERGADERING - BOEKJAAR
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2026
Annual accounts 20262,5 M €↑
2025
Annual accounts 20252 M €↑
2024
Annual accounts 20241,7 M €↑
2023
Annual accounts 20231,7 M €↓
2021
Annual accounts 20211,8 M €↑
2020
Annual accounts 2020288,4 k €↓
2019
Annual accounts 2019472,7 k €↑
2018
Annual accounts 2018170,9 k €↑
2017
Annual accounts 2017-28,7 k €
17/05/2016
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

SOFARMEX

Overview

What does SOFARMEX do?

Trend over 9 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline